Featured News Headlines
BIO Crypto Rises on Clinical Research Backing and Staking Demand
Amid a broader market correction, Bio Protocol (BIO) is showing notable resilience. The token spiked to a daily high of $0.1514 before correcting slightly to $0.1301, still maintaining a 25% gain over the last 24 hours. Its market cap now stands at $217.58 million.
Daily Volume Jumps Over 700%
BIO’s trading volume increased by a staggering 720.24%, reaching $443.47 million. The sharp uptick in interest is likely fueled by recent project developments that enhance both the token’s scarcity and utility.
Clinical Trial Funding Adds Real-World Use Case
A key catalyst behind the momentum is Cerebrum DAO, a protocol built on the Bio Protocol platform. The DAO recently approved its first funding initiative—an $80,000 grant toward a human clinical trial for Percepta, a brain health supplement targeting memory loss and neurodegeneration.
The funding will be provided by Bio Protocol. In return, the project will receive CLAW tokens, which are linked to future royalty earnings from the supplement. This creates a direct connection between BIO’s ecosystem and the potential commercial success of a biotech product.
Token Staking and Utility Growth
On the tokenomics front, staking activity has also increased. Over 125 million BIO tokens are now staked—representing 3.5% of the circulating supply. Staked tokens generate BioXP, which gives holders access to exclusive assets and opportunities within the Bio ecosystem.
A New Crypto Layer for Biotech Funding
Launched in December 2024, Bio Protocol aims to become a decentralized funding layer for the biotech industry. While biotech remains a high-risk sector, it offers potentially high rewards—making it a fitting match for the crypto investment model.
